Risk factors and predictors of levodopa-induced dyskinesia among multiethnic Malaysians with Parkinson's disease

Hashim HZ 1 , Norlinah MI , Nafisah WY , Tan HJ , Raymond AA , Tamil AM

Affiliations 

  • 1 1Neurology Unit, Department of Medicine, Universiti Kebangsaan Malaysia Medical Center (UKMMC) , Kuala Lumpur , Malaysia
Int J Neurosci, 2014 Mar;124(3):187-91.
PMID: 23952588 DOI: 10.3109/00207454.2013.833511

Abstract

Chronic pulsatile levodopa therapy for Parkinson's disease (PD) leads to the development of motor fluctuations and dyskinesia. We studied the prevalence and predictors of levodopa-induced dyskinesia among multiethnic Malaysian patients with PD.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications